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Esophageal squamous cell carcinoma (ESCC) is a 
common cancer worldwide and has a very high mortali­
ty rate [1]. The most characteristic feature of ESCC is 
its distinct geographical incidence, which suggests a 
dominant role of environmental factors in the etiology 
of this disease. Furthermore, the other risk factors such 
as nutrition imbalance (lack or absence of vitamins 
and minerals), improper life style (cigarette smoking 
and consumption of pickled food), exposure to nitros­
amines, may be implicated in the carcinogenesis of 
ESCC [1–2]. Nevertheless, the real causes and the 
mechanisms of ESCC have not been elucidated yet. 
Human papillomavirus (HPV) has been reported in 
ESCC since the observation of condyloma­like lesions 
in ESCCs 24 years ago [3]. However, the reported HPV 
infection rates in ESCC, detected as presence of viral 
proteins or DNA sequences, vary from 0% to over 60% 
worldwide [4]. This variation may resulted partly from 
the varied disease incidence in different geographical 
regions [4], partly from variations in the specificity and 
sensitivity of the analytical techniques used [5, 6]. 
Shantou, located in the coastal region of Eastern 
Guangdong, Southern China, is one of the six high 
incidence regions of esophageal carcinoma in China. 
As we reported, the total infection rate of the high­
risk HPV types 16 and 18 was very high in cancerous 
tissues (54.5%) by the means of polymerase chain 
reaction (PCR) from surgically resected esophageal 
carcinoma [7, 8]. 
To further investigate the prevalence of HPV infec­
tion in ESCC, 60 ESCC samples and pair­matched 
distal normal epithelia samples were constructed into 
one tissue microarray block. HPV16/18 E6, a major viral 
oncogene of high­risk HPV type, was studied by the 
means of immunohistochemistry (IHC), and HPV pan 
probes were used for in situ hybridization (ISH). In the 
meanwhile, the expressions of p53, p21, MDM2, cyclin 
D1 and Ki67 proteins, which are associated with cell 
cycle abnormalities and cell proliferation, were also 
analyzed by IHC method. 
MATERIALS AND METHODS 
ESCC samples and tissue microarray. Sixty 
pairs of paraffin­embedded ESCC specimens and 
pair­matched adjacent “normal” tissues were chosen 
to create one tissue microarray (TMA) block. Among 
them, 29 cases were collected from the Department 
of Pathology at the Second Affiliated Hospital of Shan­
tou University, 31 cases — from the Tumor Hospital of 
Shantou University Medical College from May 2004 to 
May 2005. The mean age of patients was 58.1 years 
(range, 43–78) and male to female ratio was 4 : 1 
(48 : 12). The ESCC case’s distributions among Grade 
1, 2, 3 were 11, 24, 25 respectively. All hematoxylin and 
eosin (H&E)­stained sections were reviewed to confirm 
the original findings and to define representative tumor 
regions. Tumor stage and grade were defined accord­
ing to the WHO histological classification criteria [9]. 
1.0 mm cores were taken from selected tissue 
blocks as typical of the specific diagnosis. The TMA 
block was created using a tissue arrayer (Beecher 
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Instruments, Silver Spring, MD) in the Cybrdi Biote­
chical Company in Xi’an, P.R. China. The TMA block 
containing 120 cores of ESCC and paired controls, was 
sectioned into 4 μm thick consecutive sections, then 
these sections were placed on slides pretreated with 
aminopropyltriethoxysilane (APES, Sigma), the slides 
were allowed to dry overnight at 42 °C, and stored at 
4 °C for later use. 
Immunohistochemical staining (IhC). The avi­
din­biotin­peroxidase complex method was used. In 
brief, first, the slides were deparaffinized in xylene, 
endogenous peroxidase was inactivated by immersing 
the slides in a 0.3% hydrogen peroxidase — methanol 
solution for 30 min at room temperature, and cross­
reactivity was blocked with the normal goat serum. 
Next, the varied antigen retrieval method, high pres­
sure or microwave methods, was performed in 0.1 mM 
citrate buffer (pH 6.0). Third, the sections were incu­
bated overnight at 4 °C with a diluted solution of the 
primary antibodies (Table 1). Location of the primary 
antibodies was achieved by subsequent application of 
a biotinylated anti­primary antibody, an avidin­biotin 
complex conjugated to horseradish peroxidase, and 
diaminobenzidine. The slides were counter­stained by 
hematoxylin. Negative controls were established by 
replacing the primary antibody with PBS and normal 
goat serum. Known immunostaining positive slides 
were used as positive controls. 
The criteria of positive staining [10, 11] were partly 
followed in this study. Briefly, for the immunohisto­
chemistry of p53 and p21Waf1, cyclin D1, and Ki67 only 
nuclear staining was observed. In contrast, HPV16/18 
E6 and MDM2 showed both in nuclear and cytoplas­
mic immunostaining. The immunoreactivity for all the 
proteins investigated in this study was evaluated as 
strongly positive (++) when more than 50% of tumor 
cells were stained, positive (+) when more than 25% of 
the cells were stained, slightly positive (±) when more 
than 10% of the tumor cells were stained, and nega­
tive (–) when less than 10% of the tumor cells were 
stained or when the tumor cells completely lacked 
immunoreactivity. All slides were observed by two 
independent pathologists, and the final concordant 
results were adopted. 
In situ hybridization (ISh). In situ hybridization 
procedures were performed according to manufac­
ture’s instruction (K1602, Dako). Briefly, the TMA 
slides were dewaxed in xylene, hydrated, digested in 
preheated pepsin­HCl at 37 °C for 7 min. After dehydra­
tion, the hybridization probes (wide spectrum HPV 
DNA probe cocktail: HPV 6, 11, 16, 18, 31, 33, 35, 45, 
51 and 52, biotinylated, Y1404, Dako) were pipetted 
on the sections, which were placed under coverslips 
and denatured at 95 °C for 5 min. Hybridization was 
carried out in a humidified chamber at 37 °C for 60 min, 
after that each section was rinsed twice in Tris buff­
ered saline for 3 min at room temperature, and then 
in preheated stringent wash solution included in the 
test kit at 48 °C for 30 min. Finally, the sections were 
incubated first with streptavidin­AP reagent at room 
temperature for 20 min and then with chromogen 
solution (BCIP/NBT) at room temperature in the dark 
for 60 min. Sections of known positivity and negativity 
were used as internal controls. 
Statistical analysis. Basic statistical calculations 
were performed using the statistical Package for Social 
Science/PC windows (SPSS). Fisher exact χ2 test was 
used for statistical analysis of the results. Correlations 
between two parameters were performed using the 
Spearman’s rank correlation test. Two­sided P va­
lues < 0.05 were considered to be significant. 
RESuLTS 
Positive rate for HPV16/18 E6 expression by ICH 
was 18.3% (11/60) in ESCC cases, only two cases 
(2/60, 3.3%) showed mild expression in pair­matched 
adjacent normal tissues. By contrast, the positive rate 
by HPV ISH was 40.0% (24/60) in the same ESCC 
TMA tissues, 9 cases (9/60, 15.0%) showed positive 
staining in control tissues. There was significant dif­
ference between HPV16/18 E6 expression in tumor 
tissues and control tissues (p < 0.01, Fisher’s exact 
test) (Table 2). 
The positive staining of p53, p21Waf1, cyclin D1 and 
Ki67 expression was observed mainly in the nuclei of 
cells in ESCC tissues (60.0% (36/60), 40.0% (24/60), 
51.7% (31/60), and 88.3% (53/60), respectively). 
MDM2 was expressed both in nuclei and cytoplasm 
(Figure) yielding 65.0% (39/60) in ESCC samples. 
Compared with the paired controls, the expression of 
mentioned proteins was significantly different in ESCC 
samples (see Table 2). 
Among five detected proteins, expression of p53, 
MDM2 and Ki67 had statistical correlations with the 
HPV16/18 E6 protein expression (p < 0.05, Table 3), 
and also, expression of MDM2 and Ki67 proteins 
seems to correlate with HPV expression (ISH) (p < 0.01, 
Table 4).  
The case distribution of five stained proteins ac­
cording to grade stage is shown in Table 5. There is 
a statistically significant correlation between Ki67 
expression and ESCC grades (p < 0.01). The expres­
sion of other proteins seems to have no correlation 
with tumor’s grade (p > 0.05). 
Statistical analysis revealed a positive correla­
tion between the expression of p21Waf1 and MDM2, 
cyclin D1 expressions in tumor tissues, and no cor­
relation between Ki67 and p21Waf1 (Table 6).  
DIScuSSION 
During the past two decades, several studies have 
shown the relationship between HPV and esophageal 
cancer (EC), however with conflicting data [2, 4, 6, 
19], which may be attributed to the geographical 
location with respect to either low or high incidence 
areas [20]. Shantou, located in southeast of China, is 
one of six HPV­high incidence regions of the world. It 
was reported that the total HPV infection rate is about 
54.5% in EC tissues using PCR method [7]. In pre­
sent study, IHC for HPV16/18 E6 and ISH for pan HPV 
methods were applied, and the results showed 11 out 
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of 60 positive (18.3%) by the former method, 24 out 
of 60 positive (40.0%) by the latter one.
The discrepancy of two HPV detecting methods 
in the same paraffin TMA tissues can be explained as 
follows: firstly, the IHC method for HPV16/18 E6 is only 
tested for the subtype of HPV16/18 E6 proteins, while 
HPV DNA cocktail probe for ISH has a wide spectrum; 
secondly, HPV DNA is more constant than their pro­
teins in the paraffin tissues. 
In this paper, we still find that there is statistically 
significant difference in HPV detection between ESCC 
tissues and control tissues (p < 0.01). So our results still 
support the earlier findings that HPV infection may play a 
role in the development of esophageal cancer [7].
It is reported that tumor suppressor proteins p53 
and p21Waf1 play important roles in regulating G1 phase 
progression, which is the key modulation point in the 
cell cycle [10, 12, 21]. But the role of these alterations 
and the mechanisms underlying the interaction between 
various risk factors in EC are still unclear. In current 
study, HPV16/18 E6, p53 and associated proteins were 
assayed on consecutive sections from the same TMA 
block. The results showed that all studied proteins were 
expressed significantly different in ESCC and normal 
tissues (p < 0.01), and moreover, p53, MDM2, and Ki67 
expression correlated with that of HPV16/18 E6, which 
is consistent with result of Bahnassy et al. [22]. 
MDM2 (murine double minute 2) gene product can 
interact with both wildtype and mutant p53 and inhibit its 
ability to act as a transcription factor, it can also abolish 
the ability of p53 to induce cell cycle arrest and apopto­
sis [13–15, 23]. So, high frequency of MDM2 expression 
in our study and correlation with HPV E6 and p53, sug­
gest that MDM2 and p53 genes may be involved in the 
pathogenetic cascade of HPV­associated EC. 
p21Waf1 protein was detected in 24 of the 60 cases 
(40%) of ESCC in present study, which is lower than 
Bahnassy’s report (64%) [22], but higher than Yang’s 
report (30%) [23]. Correlation analysis showed the 
expression of p21Waf1 seemed have low correlation 
with these of HPV16/18 E6 and p53. This result is sup­
ported by the idea that expression of p21 is regulated 
negatively by p53 [24] and the reports of Natsugoe 
[25]. It has been reported that p21Waf, which encodes 
Table 1. Summary of specific monoclonal antibodies used in the immunohistochemical analysis 
Antibodies Clone Dilution Antigen pretreatment Staining pattern Positive control
p53 Monoclonal DO7 1 : 50 High pressure Nuclear Breast cancer
p21Waf1 Monoclonal 4D10 1 : 50 Microwave Nuclear Lung cancer
MDM2 Monoclonal Sup14 1 : 50 Microwave Nuclear and cytoplasmic Osteosarcoma
Ki67 Monoclonal SP6 1 : 100 High pressure Nuclear Cervical cancer
Cyclin D1 Monoclonal SP4 1 : 100 Microwave Nuclear Cervical cancer
HPV16/18 E6 Monoclonal CIP5 1 : 50 High pressure Nuclear and cytoplasmic Cervical cancer
All monoclonal antibodies used were purchased from Maixin_Bio (China). 
Table 2. Expression of p53, p21Waf1, MDM2, Ki67, Cyclin D1, HPV E6 in ESCC samples and pair-matched controls 
Sample p53 p21
Waf1 MDM2 Ki67 Cyclin D1 HPV E6 (IHC) HPV E6 (ISH)
+ – + – + – + – + – + – + –
ESCC 36 24 24 36 39 21 53 7 31 29 11 49 24 36
Control 9 51 14 46 8 52 13  47 14 46 2 58 9 51
p* < 0.01 0.03 < 0.01 < 0.01 < 0.01 < 0.01 < 0.01
*p: Fisher’s exact test; in this and other tables are present the number of cases. 
Table 3. Relationship between expression of p53, p21Waf1, MDM2, Ki67, Cyclin D1, and HPV 16/18 E6 in collected tissues
HPV16/18 E6 p53 p21Waf1 MDM2 Ki67 Cyclin D1
– ± +  ++ – ± + ++ – ± + ++ – ± + ++ – ± + ++
– 69    4 10 22 71    11 14 9 67    9 15 15 51      11 19 25 66    11 17 11
+ 5         0 3 7 9      3 3 0 4      2 5 3 2      1 5 6 7      3 3 2
p 0.026* 0.672 0.019* 0.016* 0.567
p value: Spearman correlation; in this and other tables are presented the number of cases.
Table 4. Relationship between expressions of p53, p21Waf1, MDM2, Ki67, Cyclin D1, and HPV (ISH) in collected tissues 
HPV ISH p53 p21Waf1 MDM2 Ki67 Cyclin D1
– ± +  ++ – ± + ++ – ± + ++ – ± + ++ – ± + ++
– 57    4 6 19 59     8 11 7 58    6 11 10 47    6 13 20 57     8 14 7
+ 17    1 5 11 22     6 4 3 15     3 9 8 7    6   10 11 18     5 6 5
p 0.102 0.730 0.004* 0.004* 0.154
p value: Spearman correlation. 
Table 5. Relationship between expression of p53, p21Waf1, MDM2, Ki67, Cyclin D1 and tumor grade 
Tumor Grade p53 p21Waf1 MDM2 Ki67 Cyclin D1
– ± +  ++ – ± + ++ – ± + ++ – ± + ++ – ± + ++
I 7         1 0 3 6     3 2 2 3       0 4 4 3         8 0 0 6     1 4 1
II 8        1 3 13 12    4 4 3 5     4 9 6 0        1 23 0 14     0 3 7
III 8         0 4 12 16     4 2 2 11     3 6 5 3       0 0 22 7         4 9 4
p 0.227 0.730 0.103 0.001* 0.120
p value: Spearman correlation.
Table 6. Relationship between expression of p21Waf1 and p53, MDM2, cyclin D1, Ki67 in tumor tissues
p21Waf1 p53 MDM2 Cyclin D1 Ki67– ± +  ++ - ± + ++ – ± + ++ - ± + ++
– 14 0 5 15 14 3 12 5 20 3 8 3 5 4 12 13
± 1 1 1 7 4 1 3 3 4 1 3 2 1 2 4 4
+ 5 0 1 2 0 2 2 2 2 1 2 4 1 2 3 2
++ 3 1 1 3 1 1 1 5 2 0 4 1 1 1 3 2
p 0.930 0.011* 0.008* 0.851
p value: Spearman correlation. 
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Figure. Immunohistochemical and In Situ Hybridization (ISH) staining of HPV and associated proteins in esophageal squamous 
cell carcinoma on tissue microarrays slices. a) Ki67 positive staining × 400; b) HPV16/18 E6 positive staining × 400; c) Cyclin D1 
positive staining × 400; d) p53 positive staining × 400; e) MDM2 positive staining× 200; f) MDM2 positive staining × 400; G) p21Waf1 
positive staining × 400; h) ISH Positive staining(NBT/BCIP) × 400 
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an inhibitor of cyclin­dependent protein kinase, is 
directly activated by wild type p53 and can suppress 
the growth of human cells by inhibiting the activity of 
cyclin dependent kinases, which are required for the 
G1 to S transition of the cell cycle [26, 27]. All these 
results suggested that p21 may progress via the p53­
independent than the p53­dependent pathway in the 
pathogenesis of ESCC. Our results also showed that 
the expression of p21Waf1 has correlation with that of 
MDM2 (p < 0.01) and cyclin D1 (p < 0.01). 
Cyclin D1 also plays an important role in enhancing 
EC cell transformation [18, 28]. In human ESCC, cyclin 
D1 overexpression is already evident in dysplasias and 
early cancers [29]. In current study, 31 of 60 ESCC tumor 
tissues (51.7%) and 14 of 60 (23.3%) of their adjacent tis­
sues showed positive cyclin D1 expression (p < 0.01). Our 
results showed higher values than recently report (32% of 
EC specimens) [30, 31], and close to the other report (cy­
clin D1 positive expression rate was 56.5%) [32]. Cyclin 
D1, a protein derived from the PRAD1 on chromosome 
11q13, is one of the most essential proteins for controlling 
the cell cycle in the p16­cyclin D1­pRb pathway [33, 34]. 
In our study, expression of cyclin D1 had no correlation 
with HPV E6 and p53 but seemed to have correlation 
with that of p21Waf1 (p < 0.01) (Table 6). The relationship 
between p21Waf1 and cyclin D1 in esophageal cancer will 
be determined in the future studies.  
Ki67 is also known as a marker for cell proliferation 
[18, 35]. In present study, the expression rate of Ki67 is 
88.3% (53/60) in tumor tissues and 21.7% (13/60) in 
pair­matched controls, and Ki67 expression correlated 
with the tumor grade. 
In conclusion, Ki67 can reflect the proliferation 
status of esophageal carcinoma, p53 and MDM2 may 
contribute to the HPV16/18 E6 pathogenetic cascade 
of EC, but p21Waf1 may not play a role in the process of 
its development. Further studies to explore the mo­
lecular mechanisms of participation of these proteins 
in EC development should be performed.  
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Экспрессия HpV16/18 E6, p53, p21waf1, MDM2, Ki67 
и циклина D1 в ткани плоскоклеточной карциномы 
пищевода
Цель: исследовать роль онкогена HPV16/18 E6 вируса папилломы человека (HPV) в развитии плоскоклеточной карциномы 
пищевода (ESCC). Материалы и методы: исследованы 60 образцов ESCC и контрольные образцы нетрансформированной 
ткани (парафиновые блоки). Для выявления экспрессии белков HPV16/18 E6, p53, p21Waf1, MDM2, Ki67 и циклина D1 в срезах 
для тканевых микрочипов (tissue microarray, TMA) применен метод иммуногистохимии (IHC), для определения экспрессии 
генов HPV применяли гибридизацию in situ (ISH). Результаты: методами IHC, экспрессия HPV16/18 E6 выявлена в 18,3% 
(11/60) случаев ESCC, в то время как по результатам метода ISH, 40,0% (24/60) образцов признаны HPV-позитивными. 
В образцах ESCC экспрессия p53, p21Waf1, циклина D1, MDM2 и Ki67 выявлена в 60,0% (36/60), 40,0% (24/60), 51,7% (31/60), 
65,0% (39/60) и 88,3% (53/60) случаев соответственно, причем экспрессия p53, MDM2 и Ki67 коррелировала с экспрессией 
HPV16/18 E6 (p < 0,01), экспрессия p21Waf1 — с таковой MDM2 и циклина D1, а экспрессия Ki67 — со стадией развития 
опухоли (p < 0.01). Выводы: HPV может являться одним из этиологических факторов развития рака пищевода в провинции 
Шанту, Китай. Белки p53 и MDM2 могут принимать участие в патогенезе плоскоклеточного рака пищевода, ассоциированного 
с вирусом папилломатоза. 
Ключевые слова: вирус папилломы человека, плоскоклеточный рак пищевода, тканевый микрочип, иммуногистохимия.
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